Zohar Sachs
@SachsZohar
Followers
62
Following
48
Media
6
Statuses
62
Leukemia Researcher: My lab works on understanding all aspects of TP53 mutant AML and MDS. #AML, #p53, #LeukemiaStemCells, #UniversityofMinnesota
Joined August 2019
our new paper: a novel subtype of AML that phenocopies TP53 mutant AML! My stellar graduate student @YoonkyuLee020 and collaborator, Chad Myers, used machine learning approaches to make this discovery. Million thanks the awesome reviewer and to collaborator @lbaughn.
1
0
2
RT @Doulatov_lab: I am thrilled to share our latest work in @CellStemCell which discovers that 5q deletion of lamin B1 in myeloid malignan….
cell.com
Abnormal nuclear morphology is a hallmark of cancerous cells. Here, Reilly et al. demonstrate that deletion of lamin B1, which is common in myeloid malignancies, causes acquired Pelger-Huët nuclear...
0
28
0
My #ASH23 highlight: watching my fantastic student, @YoonkyuLee020, present a new scRNA seq analysis method that he developed with terrific collaborator, Chad Myers, (paper 0241).
0
0
13
RT @babal_jha: Beautiful talk using forward genetic screen to identify ERG as a major contributor MDS progression to secondary AML in the m….
0
4
0
RT @sghmd: Meanwhile the @umnmedschool @MHealthFairview physicians and staff are focused and working very hard. We just quietly became the….
startribune.com
U executives questioned the leadership of Fairview's "highly compensated" CEO; Fairview said the U wasn't taking shared responsibility for financial problems, in letters obtained by the Star Tribune.
0
2
0
RT @chadinabhan: Tom on #HealthcareUnfiltered, I host @lbaughn & @akkari_yassmine two dedicated scientists to tackle & simplify the top….
0
9
0
RT @Morrison4MN: We passed the PRO Act off the Senate floor! After 15 hours of debate, we are tired but jubilant. When @GovTimWalz signs it….
0
163
0
RT @Ramikomrokji: Our new manuscript, kudos to @MikkaelSekeres leading this effort and grateful to the FDA vision to get this panel togethe….
aacrjournals.org
Abstract. Myelodysplastic syndromes (MDS) have historically been challenging diseases for drug development due to their biology, preclinical modeling, and the affected patient population. In April...
0
19
0
RT @ItaiYanai: A big part of the scientific process is just having someone to talk to. If you can spare a few minutes, ask a colleague what….
0
62
0
So excited to have NK cell expert and UMN Heme/Onc/Transplant alum, @romeerizwan back in Minnesota today! Looking forward to a terrific talk and catching up with a dear friend #bmt
1
0
11
RT @AACR: Stanley Adoro, #aacrAMLMDS cochair @RaviMajetiMD, Eric R. Lechman, and @DrMonicaGuzman discussed Stem Cells in a plenary session….
0
1
0
Outstanding presentation by @DrMonicaGuzman. An exciting role for the epichaperone in treating AML. Careful, well designed studies of a single patient can teach us a lot.
0
0
3
RT @PapaemmanuilLab: Wow! Coverage of the IPSS-M publication during #EHA22 ranked as the top 1 most viewed conference content in 2022 by th….
ajmc.com
The American Journal of Managed Care® covered thousands of miles in 2022, virtually and in person, criss-crossing the country and the world to deliver the latest clinical data, trial results, and...
0
7
0
Amazing great news for GVHD prophy! One of my favorite moments at ASH to see one of smartest and nicest hematologist presenting these exciting results so elegantly!!! Way to go Shernan!!! @sghmd @UMNCancer #ASH22.
1
2
19